Literature DB >> 11779241

Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.

Sami Väisänen1, Mikael Peräkylä, Jouni I Kärkkäinen, Andreas Steinmeyer, Carsten Carlberg.   

Abstract

The carboxy-terminal alpha-helix of a nuclear receptor ligand-binding domain (LBD), helix 12, contains a critical, ligand-modulated interface for the interaction with coactivator proteins. In this study, using the example of the vitamin D receptor (VDR) and the partial antagonist ZK159222, the role of helix 12 (residues 417-427) for both antagonistic and agonistic receptor actions was investigated. Amino acid residue G423 was demonstrated to be critical for partial agonism of ZK159222, but not for the activity of the natural VDR agonist, 1alpha,25-dihydroxyvitamin D(3) (1alpha,25(OH)(2)D(3)). The amount of partial agonism of ZK159222 increased when helix 12 was truncated by the last four amino acid residues (Delta424-27) and augmented even more, when in addition helix 12 of VDR's dimerization partner, retinoid X receptor (RXR), was truncated. In contrast, the low agonism of a structural derivative of ZK159222, ZK168281, was not affected comparably, whereas other close structural relatives of ZK159222 even demonstrated the same agonistic activity as that of 1alpha,25(OH)(2)D(3). The amount of agonism of ZK159222 and ZK168281 at different variations of helix 12 correlated well with VDR's ability to complex with coactivator proteins and inversely correlated with the strength of the compound's antagonistic action on 1alpha,25(OH)(2)D(3) signalling. Molecular dynamics simulations of the LBD complexed with the two antagonists could explain their different action by demonstrating a more drastic displacement of helix 12 through ZK168281 than through ZK159222. Moreover, the modelling could indicate a kink of helix 12 at amino acid residue G423, which provides the last four amino acid residues of helix 12 with a modulatory role for the partial agonism of some VDR antagonists, such as ZK159222. In conclusion, partial agonism of a VDR antagonist is lower the more it disturbs helix 12 in taking the optimal position for coactivator interaction. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779241     DOI: 10.1006/jmbi.2001.5225

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.

Authors:  Taner Kaya; Narasimha Swamy; Kelly S Persons; Swapna Ray; Scott C Mohr; Rahul Ray
Journal:  Bioorg Chem       Date:  2009-02-14       Impact factor: 5.275

2.  1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.

Authors:  Seiichi Ishizuka; Noriyoshi Kurihara; Yuko Hiruma; Daishiro Miura; Jun-ichi Namekawa; Azusa Tamura; Yuko Kato-Nakamura; Yusuke Nakano; Kazuya Takenouchi; Yuichi Hashimoto; Kazuo Nagasawa; G David Roodman
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-22       Impact factor: 4.292

3.  Ligand unbinding pathways from the vitamin D receptor studied by molecular dynamics simulations.

Authors:  Mikael Peräkylä
Journal:  Eur Biophys J       Date:  2008-10-03       Impact factor: 1.733

Review 4.  Inhibitors for the Vitamin D Receptor-Coregulator Interaction.

Authors:  Kelly A Teske; Olivia Yu; Leggy A Arnold
Journal:  Vitam Horm       Date:  2015-11-30       Impact factor: 3.421

5.  Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications.

Authors:  Sepideh Yaghmaei; Christopher Roberts; Rizi Ai; Mathew T Mizwicki; Chia-En A Chang
Journal:  In Silico Pharmacol       Date:  2013-02-12

6.  Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia.

Authors:  Daniela Rovito; Anna Y Belorusova; Sandra Chalhoub; Anna-Isavella Rerra; Elvire Guiot; Arnaud Molin; Agnès Linglart; Natacha Rochel; Gilles Laverny; Daniel Metzger
Journal:  Nat Commun       Date:  2020-12-07       Impact factor: 14.919

Review 7.  Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.

Authors:  Lin-Yan Wan; Yan-Qiong Zhang; Meng-Di Chen; You-Qin Du; Chang-Bai Liu; Jiang-Feng Wu
Journal:  Molecules       Date:  2015-11-18       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.